Portfolio Company · Operating Co.

Dorian Therapeutics

Not on record

backed byBlumberg Capital

Current

Dorian Therapeutics

a portfolio company of

Blumberg Capital

Status on record: Current

PE Firm Index

Who owns Dorian Therapeutics?

Dorian Therapeutics is listed as a current portfolio company of Blumberg Capital on Blumberg Capital's own portfolio page.

Company Snapshot

Dorian Therapeutics' owner on record, Blumberg Capital, is a firm. Blumberg Capital lists 114 companies in the index.

SectorNot on record

Parent PE firmBlumberg Capital

Ownership statusCurrent

WebsiteNot on record

About the owner

Blumberg Capital

Companies in the index: 114

Early and growth-stage venture capital firm investing in technology companies.

Read the Blumberg Capital profile

Questions about Dorian Therapeutics

Who owns Dorian Therapeutics?

Dorian Therapeutics is listed as a current portfolio company of Blumberg Capital on Blumberg Capital's own portfolio page.

Sources

Blumberg Capital's page on Dorian Therapeutics
Blumberg Capital
https://blumbergcapital.com/companies

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Dorian Therapeutics and does not provide investment advice.

Other portfolio companies of Blumberg Capital

6 of 113 shown

See the full Blumberg Capital portfolio.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Blumberg Capital

Status: Current

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.